HINGHAM, Mass. , June 09, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, closed its previously announced registered direct offering of 3,750,000 shares of
